Literature DB >> 16884691

A novel type of EWS-CHOP fusion gene in myxoid liposarcoma.

Yoshito Matsui1, Takafumi Ueda, Takahiro Kubo, Tadashi Hasegawa, Yasuhiko Tomita, Mina Okamoto, Akira Myoui, Shigeki Kakunaga, Natsuo Yasui, Hideki Yoshikawa.   

Abstract

The cytogenetic hallmark of myxoid type and round cell type liposarcoma consists of reciprocal translocation of t(12;16)(q13;p11) and t(12;22)(q13;q12), which results in fusion of TLS/FUS and CHOP, and EWS and CHOP, respectively. Nine structural variations of the TLS/FUS-CHOP chimeric transcript have been reported, however, only two types of EWS-CHOP have been described. We describe here a case of myxoid liposarcoma containing a novel EWS-CHOP chimeric transcript and identified the breakpoint occurring in intron 13 of EWS. Reverse transcription-polymerase chain reaction and direct sequence showed that exon 13 of EWS was in-frame fused to exon 2 of CHOP. Genomic analysis revealed that the breaks were located in intron 13 of EWS and intron 1 of CHOP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884691     DOI: 10.1016/j.bbrc.2006.07.085

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Variation in myxoid liposarcoma: Clinicopathological examination of four cases with detectable TLS-CHOP or EWS-CHOP fusion transcripts whose histopathological diagnosis was other than myxoid liposarcoma.

Authors:  Kayo Suzuki; Yoshito Matsui; Nobuyuki Hashimoto; Norifumi Naka; Nobuhito Araki; Tomoatsu Kimura; Hideki Yoshikawa; Takafumi Ueda
Journal:  Oncol Lett       Date:  2011-11-15       Impact factor: 2.967

2.  Multifocal myxoid liposarcoma--metastasis or second primary tumor?: a molecular biological analysis.

Authors:  Ronald de Vreeze; Daphne de Jong; Petra Nederlof; Henrique J Ruijter; Lucie Boerrigter; Rick Haas; Frits van Coevorden
Journal:  J Mol Diagn       Date:  2010-01-21       Impact factor: 5.568

Review 3.  Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas.

Authors:  Alessandro De Vita; Laura Mercatali; Federica Recine; Federica Pieri; Nada Riva; Alberto Bongiovanni; Chiara Liverani; Chiara Spadazzi; Giacomo Miserocchi; Dino Amadori; Toni Ibrahim
Journal:  Onco Targets Ther       Date:  2016-10-11       Impact factor: 4.147

Review 4.  Molecular detection and targeting of EWSR1 fusion transcripts in soft tissue tumors.

Authors:  Monica Cantile; Laura Marra; Renato Franco; Paolo Ascierto; Giuseppina Liguori; Annarosaria De Chiara; Gerardo Botti
Journal:  Med Oncol       Date:  2013-01-18       Impact factor: 3.064

5.  Massive edema of ovary with cytogenetic alteration of chromosome 12q13-15 in adolescent patient: a case report.

Authors:  Rossella De Cecio; Monica Cantile; Nicola Fortunato; Annarosaria De Chiara; Nunzia Simona Losito; Renato Franco; Gerardo Botti
Journal:  J Ovarian Res       Date:  2013-02-07       Impact factor: 4.234

6.  Myxoid liposarcoma-associated EWSR1-DDIT3 selectively represses osteoblastic and chondrocytic transcription in multipotent mesenchymal cells.

Authors:  Kayo Suzuki; Yoshito Matsui; Mami Higashimoto; Yoshiharu Kawaguchi; Shoji Seki; Hiraku Motomura; Takeshi Hori; Yasuhito Yahara; Masahiko Kanamori; Tomoatsu Kimura
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

7.  Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas.

Authors:  Jun Nishio; Hiroshi Iwasaki; Kazuki Nabeshima; Masatoshi Naito
Journal:  Genet Res Int       Date:  2011-07-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.